TagTIC Target mining for the development of therapeutics against pathogen-induced cancers
- Coordinator
- Paris-Lodron-Universitat Salzburg, Austria
- Runs
- 1 January 2027 to 31 December 2031
- Status
- Running
- EU funding
- €4.3m
- Total cost
- —
- Partners
- 23 organisations in 9 countries
- Type
- Marie Skłodowska-Curie Action
- Grant agreement
- 101311627
What the project is doing
In the project's own words, from its summary on CORDIS.
Gastrointestinal cancers, including gastric and colorectal cancer, are among the most prevalent and lethal malignancies worldwide. Growing evidence highlights the microbial agents Fusobacterium nucleatum, Helicobacter pylori, or Epstein-Barr Virus as prominent key drivers of cancer initiation and progression by disrupting epithelial signaling, promoting chronic inflammation, and evading immune surveillance. However, current therapeutic strategies and model systems rarely address pathogenic tumorigenesis or progression and altered drug efficacy in the presence of these pathogens, leaving a critical gap in the development of precise and preventive treatments.
TagTIC addresses this challenge through a systems medicine approach that integrates microbiology, cancer biology, drug discovery, and artificial intelligence. By using innovative preclinical organoid model systems that closely resemble patient conditions, TagTIC aims to decipher complex host-pathogen interactions at single-cell and spatial resolution and to address them therapeutically. Research will focus on: (i) identifying vulnerable molecular nodes involved in pathogen-associated cancers; (ii) developing novel strategies for lead discovery and treatment; (iii) generating and analyzing innovative ex vivo models using 2D/3D cultures, patient-derived organoids, and organ-on-chip technologies.
The network will train eleven Doctoral Candidates (DCs) towards translational leaders, capable of analyzing and solving complex biomedical needs with innovative strategies and approaches. DCs will follow a structured training program combining basic and translational science with cross-sectoral exposure to academia and industry. The collaboration between nine beneficiaries and 14 associated partners ensures a strong curriculum, interdisciplinary mentorship, and international mobility to empower DCs for careers in academia, biotech, pharma, and socio-economic sectors across Europe.
Topics
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| Paris-Lodron-Universitat Salzburg | Salzburg | Austria | Coordinator |
| Gemeinnutzige Salzburger Landeskliniken Betriebsgesellschaft | Salzburg | Austria | Associatedpartner |
| Molecular Devices (Austria) GmbH | Urstein bei Hallein | Austria | Associatedpartner |
| Tissuegnostics GmbH | Wien | Austria | Participant |
| G2L Services Limited | etobicoke | Canada | Associatedpartner |
| Abberior Instruments GmbH | Gottingen | Germany | Associatedpartner |
| Deutsches Krebsforschungszentrum Heidelberg | Heidelberg | Germany | Participant |
| Evident Europe GmbH - Headquarter EMEA - Germany | Hamburg | Germany | Associatedpartner |
| Helmholtz Zentrum Muenchen Deutsches Forschungszentrum Fuer Gesundheit Und Umwelt GmbH | Neuherberg | Germany | Participant |
| Immunotools GmbH | Friesoythe | Germany | Associatedpartner |
| Invigate GmbH | Jena | Germany | Associatedpartner |
| MyxoTech GmbH | Saarbruecken | Germany | Associatedpartner |
| Ruprecht-Karls-Universitaet Heidelberg | Heidelberg | Germany | Associatedpartner |
| Technische Universitaet Muenchen | Muenchen | Germany | Associatedpartner |
| Universitat Des Saarlandes | Saarbrucken | Germany | Participant |
| Aarhus Universitet | Aarhus C | Denmark | Participant |
| Cobiomic Bioscience SL | Cordoba | Spain | Associatedpartner |
| Scienseed SL | Madrid | Spain | Associatedpartner |
| Universidad Autonoma De Madrid | Madrid | Spain | Participant |
| Universita Degli Studi Di Roma La Sapienza | Roma | Italy | Participant |
| Uniwersytet Gdanski | Gdansk | Poland | Participant |
| DeepMirror Ltd | Cambridge | United Kingdom | Associatedpartner |
| Meso Scale Diagnostics, LLC. | Rockville, MD | United States | Associatedpartner |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI